title: Secondary leukemia responsive to retinoic acid with abnormal localization of RARalpha protein: a report of two cases.
authors.forename: G
authors.initials: G
authors.lastname: Leone
authors.forename: S
authors.initials: S
authors.lastname: Sica
authors.forename: E
authors.initials: E
authors.lastname: Ortu La Barbera
authors.forename: U
authors.initials: U
authors.lastname: Testa
authors.forename: R
authors.initials: R
authors.lastname: Riccioni
authors.forename: C
authors.initials: C
authors.lastname: Labbaye
authors.forename: C
authors.initials: C
authors.lastname: Peschle
authors.forename: M
authors.initials: M
authors.lastname: Zollino
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D018168:Receptors, Retinoic Acid / Q000378:metabolism*; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; C000607071:RARA protein, human; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin